Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 5, Issue 2, 2006, Pages 121-124

  Lekkas, Anastasios ^a   Gyi, Khin M ^a   Hodson, Margaret E ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Burkholderia cepacia complex; Cystic fibrosis; Temocillin

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; C REACTIVE PROTEIN; OXYGEN; TEMOCILLIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA COMPLEX; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXACERBATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE COUNT; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; OXYGEN SATURATION; SPUTUM ANALYSIS; SURVIVAL RATE; TEMPERATURE MEASUREMENT; THORAX PAIN; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CYSTIC FIBROSIS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PENICILLINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33645997638     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2005.12.005     Document Type: Article

References (10)

1. Iles A., Maclusky I., Corey M., Gold R., et al. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Paediatr 104 (1984) 206-210
2. Corey M., and Farwell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 143 (1996) 1007-1017
3. Bonacorsi S., Fitoussi F., Lhopital S., and Bingen E. Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazadime in combination with tobramycin, rifampicin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 43 2 (1999) 213-217
4. Taylor R., Gaya H., and Hodson M. Temocillin and cystic fibrosis: outcome of intravenous administration in patients with Pseudomonas cepacia. J Antimicrob Chemother 29 (1992) 341-344
5. Aaron S., Ferris W., Henry D., et al. Multiple combination testing for patients with CF infected with Burkholderia cepacia. Am J Respir Crit Care Med 161 (2000) 1206-1212
6. Shannon K. Stability of temocillin to beta-lactamases. Res Clin Forums 2 5 (1990) 11-20
7. Slocome B., Brown T., and Woodnutt C.C. In vitro and in vivo activity of temocillin. Res Clin Forums 12 5 (1990) 21-31
8. Chapparo C., Mauer J., et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respr Crit Care Med 163 1 (2001) 43-48
9. Aris R.M., Routh J.C., Lpuma J.J., Heath D.G., and Gilligan P.H. Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Am J Respir Crit Care Med 164 (2001) 2102-2106
10. De Soyza A., McDowell A., Archer L., et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358 (2001) 1780-1781